Clinical Trials for Breast Cancer

32 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
Basic ScienceVICCBRE1101
02/28/2011
A Retrospective Evaluation of Clinical Breast MRIs in Patients with Localized Breast Cancer
Basic ScienceVICCBRE0767
06/11/2008
Predicting Cardiac Effects of Breast Cancer Therapy
Basic ScienceVICCBRE03103
01/22/2004
Breast Tissue/Body Fluids Repository (SPORE)
Basic ScienceVCCBRE0057
10/27/2000
Nashville Breast Health Study
DiagnosticVICCBRE1271
01/09/2013
Observational Pilot Study on MRI and Blood-Based Biomarkers of Chemotherapy-Related Cognitive Impairment
DiagnosticVICCBRE1277
01/01/2013
Ultra-High Field (7 Tesla) MRI/MRS Evaluation of Breast Cancer
DiagnosticVICCBRE09108
10/13/2010
PET/CT Evaluation of Treatment Response in Breast Cancer
DiagnosticVICCBRE0588
03/07/2006
MRI Evaluation Of Breast Tumor Growth And Treatment Response (SPORE)
OtherVICCSUPP1224
11/19/2012
Osteonecrosis of the Jaw Case (ONJ) Registry
OtherECOGBREE2Z04-M
06/11/2008
Quality of LIfe in Younger Breast Cancer Survivors
OtherCTSUBREC70301-M
06/11/2007
Quality of Life, Employment and Informal Care Cost Analysis in Women Receiving Adjuvant Chemotherapy for Breast Cancer with 0-3 Positive Axillary Lymph Nodes
OtherVICCBRE0704
02/21/2007
Developing In-Vivo Models of Human Breast Cancer
Supportive CareVICCREACH1341
09/05/2013
Using a Tailored Navigation Intervention to Prepare Patients and Their Support Person for the Journey at Time of Cancer Diagnosis and at Transition into Survivorship
Supportive CareVICCBRE1299
01/23/2013
Promoting Adherence to Lymphedema Self Care in Breast Cancer Survivors
TreatmentVICCBRE1390
04/23/2014
A Randomized Double-Blind, Placebo-Controlled Study of LEE011 in Combination with Letrozole for the Treatment of Postmenopausal Women with Hormone-Receptor Positive, HER2-negative, Advanced Breast Cancer who Received no Prior Therapy for Advanced Disease
TreatmentVICCPHI1394
04/17/2014
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients with Epithelial Cancer
TreatmentVICCBRE1385
03/03/2014
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety of Enzalutamide in Combination With Exemestane in Patients with Advanced Breast Cancer That Is Estrogen or Progesterone Receptor-Positive and HER2-Normal
TreatmentVICCPHI1359
12/03/2013
A Phase 1/2, Open-label Study of Nivolumab Monotherapy or Nivolumab combined with Ipilimumab in Subjects with Advanced or Metastatic Solid Tumors
TreatmentVICCBRE1287
09/23/2013
A Phase Ib/II Trial of GDC-0941 (a PI3K inhibitor) in combination with Cisplatin in patients with androgen receptor negative Triple Negative Metastatic Breast Cancer
TreatmentVICCPHI1333
09/18/2013
A Phase I Dose Escalation Open-Label Safety, Pharmacokinetic and Pharmacodynamic Study to Determine the Recommended Phase II Dose of GSK1120212 Dosed in Combination with GSK2141795
TreatmentVICCBRE1320
08/16/2013
A Phase Ib Open-Label, Dose-Escalation Study of the Safety and Pharmacology of GDC-0032 in Combination with Either Docetaxel or Paclitaxel in Patients with HER2-Negative Locally Recurrent or Metastatic Breast Cancer
TreatmentVICCBRE1304
06/04/2013
A Phase II Study Evaluating the Efficacy and Tolerability of Everolimus (RAD001) in Combination with Trastuzumab and Vinorelbine in the Treatment of Progressive HER2-Positive Breast Cancer Brain Metastases
TreatmentVICCBRE1298
04/19/2013
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft? Axxent? eBx System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
TreatmentVICCBREP12116
03/25/2013
An Open-Label, Phase I Study of ARN-810 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer
TreatmentVICCBRE1280
02/07/2013
A Phase III Randomized, Double Blind Placebo Controlled Study of BKM120 with Fulvestrant, in Postmenopausal Women with Hormone Receptor-Positive HER2-Negative Locally Advanced or Metastatic Breast Cancer Which Progressed On or After Aromatase Inhibitor Treatment
TreatmentVICCPHI1248
10/12/2012
An Open-Label, Phase I, Dose-Escalation Study Evaluating the Safety and Tolerability of GDC0032 in Patients with Locally Advanced or Metastatic Solid Tumors and in Combination with Endocrine Therapy in Patients with Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer
TreatmentVICCMD1188
06/08/2012
An Open-Label, Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers
TreatmentCTSUBRENB-43-M
04/26/2012
A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy
TreatmentCTSUNSABPBREB-47-M
04/26/2012
A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer 
TreatmentCTSUBRENCCTGMA32-M
04/23/2012
A Phase III Randomized Trial of Metformin versus Placebo on Recurrence and Survival in Early Stage Breast Cancer
TreatmentCTSUBRES1007-M
05/25/2011
Phase III randomized trial of standard adjuvant endocrine therapy +/- chemo in patients with 1-3 positive nodes, hormone receptor positive and Her2 negative breast cancer with recurrence score (RS) of 25 or less
TreatmentCTSUBREC40603-M
12/07/2010
Randomized Phase II 2 X 2 Factorial Trial Of The Addition Of Carboplatin +/- Bevacizumab To Neoadjuvant Weekly Paclitaxel Followed By Dose-Dense AC In Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer

You do not have JavaScript enabled. This site works better with JavaScript turned on.